XML 14 R1.htm IDEA: XBRL DOCUMENT v3.6.0.2
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2016
Mar. 20, 2017
Jun. 30, 2016
Document And Entity Information [Abstract]      
Entity Registrant Name ATOSSA GENETICS INC    
Entity Central Index Key 0001488039    
Document Type 10-K/A    
Trading Symbol ATOS    
Document Period End Date Dec. 31, 2016    
Amendment Flag true    
Amendment Description

EXPLANATORY NOTE

 

This Amendment No. 1 to the Annual Report on Form 10-K (the “Amended Form 10-K”) of Atossa Genetics Inc. (the “Company”) amends the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the Securities and Exchange Commission on March 16, 2017 (the “Original Form 10-K”) to correct an inadvertent error in the weighted average shares outstanding in the financial statements for the year ended December 31, 2016. The Company incorrectly stated the weighted average number of shares outstanding – basic and diluted for the year ended December 31, 2016 as 2,277,775 rather than the correct number of 2,947,282. The Company also incorrectly stated the loss per common share from continuing operations - basic and diluted, and loss per common share – basic and diluted, for the year ended December 31, 2016 as $(2.80) rather than the correct amount of $(2.16). As a result, the following items in the original filing have been amended:

 

Part II, Item 9A. Controls and Procedures;

Part II, Item 15. Financial Statements, Consolidated Statements of Operations; and

Part II, Item 15. Notes to Consolidated Financial Statements, Note 11 – Net Loss Per Share

 

In accordance with applicable generally accepted accounting principles, the Company has calculated and recognized adjustments accordingly. The following table shows the effect of the restatement on the Company’s financial statements for the year ended December 31, 2016:

    Year Ended December 31, 2016  
    As Previously
Reported		     Restated  
Weighted average common share outstanding used to compute net loss per share, basic and diluted     2,277,775       2,947,282  
Net loss per share of common stock, basic and diluted:                
Net loss per share from continuing operations   $ (2.80 )   $ (2.16 )
Net loss per share   $ (2.80 )   $ (2.16 )

 

Except as specifically noted above, this Form 10-K/A does not modify or update the Original 10-K or modify or update any related or other disclosures as originally filed, other than as required to reflect the effects of the amendment discussed above.Management has discussed the matters set forth above with the Company’s independent registered public accounting firm. On March 20, 2017, the Company’s Chief Financial Officer concluded that the financial statements and other financial data for the year ended December 31, 2016, as reported in the Original Form 10-K, should not be relied upon because of the error described above which has been corrected in the Amended Form 10-K. Additionally, investors, analysts and other persons should not rely upon any press releases, investor presentations or other communications that relate to that information.

    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 9,717,239
Entity Common Stock, Shares Outstanding   3,786,913  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2016